ResMed Inc.

NYSE: RMD · Real-Time Price · USD
283.89
-0.83 (-0.29%)
At close: Aug 15, 2025, 12:38 PM

ResMed Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Cash & Equivalents
1.21B 932.71M 521.94M 426.36M 238.36M 237.91M 210.25M 209.1M 227.89M 227.89M 253.2M 207.16M 273.71M 201.77M 194.48M 276.15M 295.28M 230.63M 255.87M 421.41M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a 168.61M 167.14M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
438.96M 391.43M 12.57M 111.71M 284M 277.32M 275.82M 265.11M 262.45M 270.87M 260.16M 173.43M 171.75M 169.4M 165.54M 162.99M 160.92M 150.23M 157.49M 145.52M
Receivables
939.49M 939.52M 959.75M 811.2M 837.27M 779.26M 729.74M 692.39M 704.91M 686.26M 672.27M 620.48M 575.95M 508.58M 526.04M 575.55M 614.29M 525.01M 509.36M 464.89M
Inventory
927.71M 862.64M 882.1M 917.98M 822.25M 829.46M 933.21M 958.23M 998.01M 1.01B 988.96M 864.85M 743.91M 664.94M 592.15M 506.64M 457.03M 484.06M 474.82M 478.01M
Other Current Assets
428.95M 216.16M 196.55M 212.99M 180.01M 180.77M 179.63M 161.66M 179.93M 155.51M 147.44M n/a 131.26M 220.11M 145.35M 150.08M n/a n/a n/a n/a
Total Current Assets
3.51B 3.21B 2.84B 2.64B 2.36B 2.35B 2.38B 2.3B 2.37B 2.34B 2.33B 2.03B 1.93B 1.7B 1.55B 1.59B 1.57B 1.47B 1.45B 1.54B
Property-Plant & Equipment
718.29M 687.94M 671.17M 717.28M 699.15M 686.82M 705.21M 657.4M 665.81M 656.29M 650.97M 612.7M 630.5M 654.42M 623.82M 601.72M 592.07M 583.86M 590.76M 549.29M
Goodwill & Intangibles
3.51B 3.28B 3.24B 3.36B 3.33B 3.34B 3.39B 3.38B 3.32B 3.35B 3.35B 2.28B 2.28B 2.3B 2.32B 2.3B 2.32B 2.34B 2.32B 2.33B
Total Long-Term Assets
4.67B 4.36B 4.31B 4.58B 4.51B 4.46B 4.53B 4.44B 4.38B 4.38B 4.35B 3.14B 3.16B 3.2B 3.19B 3.14B 3.15B 3.12B 3.12B 3.08B
Total Assets
8.17B 7.57B 7.14B 7.22B 6.87B 6.81B 6.91B 6.74B 6.75B 6.71B 6.68B 5.18B 5.1B 4.91B 4.73B 4.73B 4.73B 4.59B 4.57B 4.62B
Account Payables
278.16M 222.56M 220.31M 249.28M 237.73M 177.44M 202.4M 177.05M 150.76M 161.9M 196M 181.49M 159.25M 149.8M 163.37M 173.7M 138.01M 117.22M 122.17M 117.59M
Deferred Revenue
166.03M 160.44M 156.51M 157.19M 152.55M 150.75M 148.9M 146.72M 138.07M 141.04M 133.91M 108.19M 108.67M 112.45M 111.65M 112.53M 109.61M 105.34M 105.24M 102.03M
Short-Term Debt
40.41M 9.91M 9.91M 9.9M 9.9M 9.9M 9.9M 9.9M 9.9M 9.9M 9.9M 9.91M 9.92M 11.97M 12M 12M 12M 11.99M 11.99M 11.99M
Other Current Liabilities
n/a n/a n/a n/a 4.65M n/a n/a n/a 9.56M n/a n/a n/a 1.95M n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
1.05B 940.52M 851.96M 904.08M 910.65M 773.03M 764.07M 770.8M 758.53M 761.69M 732.71M 692.66M 689.3M 667.26M 621.06M 624.16M 911.77M 876.54M 577.34M 590.85M
Long-Term Debt
658.39M 663.13M 662.86M 667.58M 697.31M 997.05M 1.22B 1.35B 1.43B 1.58B 1.79B 785.44M 765.33M 668.74M 667.98M 793.67M 643.35M 719.05M 813.73M 1.04B
Other Long-Term Liabilities
111.01M 48.98M 10.83M 83.27M 42.26M 59.71M 85.05M 46.48M 105.35M 106.74M 87.79M 42.91M 54.86M 58.4M 59.59M 59.23M 69.73M 66.27M 99.53M 98.62M
Total Long-Term Liabilities
1.16B 1.08B 1.04B 1.12B 1.1B 1.41B 1.66B 1.72B 1.86B 2.02B 2.21B 1.05B 1.05B 959.2M 967.84M 1.08B 930.68M 999.95M 1.13B 1.35B
Total Liabilities
2.21B 2.02B 1.89B 2.03B 2.01B 2.18B 2.42B 2.49B 2.62B 2.78B 2.94B 1.74B 1.74B 1.63B 1.59B 1.7B 1.84B 1.88B 1.71B 1.94B
Total Debt
882.32M 839.77M 839.74M 850.24M 873.93M 1.17B 1.39B 1.5B 1.58B 1.72B 1.94B 930.63M 917.55M 832.09M 836.86M 950.11M 793.72M 868.8M 965.81M 1.19B
Common Stock
761K 761K 760K 758K 588K 588K 588K 588K 588K 588K 588K 586K 586K 585K 585K 583K 583K 582K 582K 580K
Retained Earnings
6.08B 5.78B 5.49B 5.23B 4.99B 4.77B 4.54B 4.4B 4.25B 4.09B 3.92B 3.76B 3.61B 3.48B 3.36B 3.22B 3.08B 2.94B 3.08B 2.95B
Comprehensive Income
-74.7M -250.86M -298.89M -132.16M -251.53M -265.31M -208.35M -320.15M -272.53M -261.88M -270.17M -406.13M -312.75M -224.14M -223.09M -217M -193.49M -195.97M -163.15M -240.19M
Shareholders Equity
5.97B 5.55B 5.25B 5.2B 4.86B 4.63B 4.48B 4.25B 4.13B 3.93B 3.74B 3.43B 3.36B 3.28B 3.15B 3.03B 2.89B 2.71B 2.86B 2.68B
Total Investments
n/a n/a 168.61M 167.14M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a